Gene sequencing giant expects tough market conditions to linger into 2023 as cautious customers battle inflation.
Yes
No
Based on recent headline ratings, 88% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positive.
88%
Read All
In